Community Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Community Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-722	Closed	-$404K	–	97
2020 Q3	$404K	Hold	722	–	–	0.54%	57
2020 Q2	$450K	Hold	722	–	–	0.49%	67
2020 Q1	$353K	Sell	722 -723	-50%	-$298K	0.59%	57
2019 Q4	$543K	Hold	1,445	–	–	0.52%	60
2019 Q3	$401K	Buy	1,445 +695	+93%	+$206K	0.44%	67
2019 Q2	$235K	Hold	750	–	–	0.27%	113
2019 Q1	$308K	Buy	750 +115	+18%	+$47.4K	0.37%	83
2018 Q4	$237K	Buy	+635	New	+$232K	0.35%	90

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Community Capital Management's REGN Position: Q4 2020 in Review

Community Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 722 shares — an estimated $404K sold.

Community Capital Management first reported a position in REGN in Q4 2018 and held it in 8 quarters. The position peaked at $543K in Q4 2019. 903 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

Community Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Community Capital Management sold 722 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $404K.
Community Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 8 quarters.
Community Capital Management's Regeneron Pharmaceuticals position peaked at $543K in Q4 2019.
903 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Community Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.